The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...
Zealand Pharma A/S ( (ZLDPF)) has released its Q3 earnings. Here is a breakdown of the information Zealand Pharma A/S presented to its investors. Zealand Pharma A/S is a biotechnology company ...
Analyst Keay Nakae from Chardan Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) and keeping the price target at $300.00. Keay Nakae’s rating is based on several ...
Further information can be found at: www.tmepharma.com. TME Pharma® and the TME Pharma logo are registered trademarks.
South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...
TME Pharma will be able to optimize late phase development by selecting the best performing treatment arm against standard of care. The Phase 2 results will serve as a basis for discussions with ...
SAN RAFAEL, Calif., Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences. BioMarin ...
In this whitepaper, we show that using the NFS with an appropriate module, it is possible to non-invasively measure particle size related CQAs in transparent pharmaceutical packaging of any type ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) has announced an extension of its supply agreement with STA Pharmaceutical Hong Kong Limited, as per the recent 8-K filing with the Securities and Exchange ...
What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...
Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) has announced an extension of its supply agreement with STA Pharmaceutical Hong Kong Limited, as per the recent 8-K filing with the Securities and Exchange ...